Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

A simple wash test can help differentiate between two types of hair loss, and dermatoscopy should be used for further clarification.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

Genetic differences in hair loss can help improve diagnosis and treatment.

Cimetidine is not a first-choice treatment for female hair loss, and there's no consistently successful treatment for this condition in men or normal hormone level women.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Finasteride helps increase hair growth in men with hair loss.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

Common hair loss in men can be treated with minoxidil or finasteride.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

The article suggests using "to heal from" for a more caring approach to treating women's hair loss and discusses the impact of doctors' beliefs on treatment.

Androgenetic alopecia may increase the severity of COVID-19.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Hair loss in postmenopausal woman caused by ovarian issue.

Most patients with hair loss sought treatment for cosmetic reasons, were unhappy about their appearance, and had a family history of the condition, suggesting it may be inherited.

Female pattern hair loss in Thailand varies by region and demographics, affecting diagnosis and treatment.

Acne severity is not related to the type or severity of androgenetic alopecia.

Androgenetic alopecia is less common in Chilean Mapuche than Caucasians, but more common than Asians, with racial differences in prevalence and types.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Low iron levels are linked to hair loss in women.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.